APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Adrenocorticotropic Hormone Receptor

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Adrenocorticotropic Hormone Receptor Market Analysis and Forecast 2026-2032

Report ID 173960810219 December 2025190 pages

Choose your research edition.

Industry ResearchAdrenocorticotropic Hormone Receptor Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Adrenocorticotropic Hormone Receptor Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Adrenocorticotropic Hormone Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Adrenocorticotropic Hormone Receptor Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Adrenocorticotropic Hormone Receptor Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Adrenocorticotropic Hormone Receptor market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Adrenocorticotropic Hormone Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Adrenocorticotropic Hormone Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Adrenocorticotropic Hormone Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Adrenocorticotropic Hormone Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Adrenocorticotropic Hormone Receptor include Pfizer Inc., XOMA Corporation, Retrophin Inc., Mallinckrodt Plc, Ipsen S.A. and Alder Biopharmaceuticals Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Adrenocorticotropic Hormone Receptor, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Adrenocorticotropic Hormone Receptor, also provides the revenue of main regions and countries. Of the upcoming market potential for Adrenocorticotropic Hormone Receptor, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Adrenocorticotropic Hormone Receptor revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Adrenocorticotropic Hormone Receptor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Adrenocorticotropic Hormone Receptor revenue, projected growth trends, production technology, application and end-user industry.

Adrenocorticotropic Hormone Receptor Segment by Company

Pfizer Inc.

XOMA Corporation

Retrophin Inc.

Mallinckrodt Plc

Ipsen S.A.

Alder Biopharmaceuticals Inc.

Adrenocorticotropic Hormone Receptor Segment by Type

Corticotropin

BIM-23B065

AQB-565

Others

Adrenocorticotropic Hormone Receptor Segment by Application

Acromegaly

Cushing Disease

Hormonal Disorder

Musculoskeletal Disorder

Others

Adrenocorticotropic Hormone Receptor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adrenocorticotropic Hormone Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Adrenocorticotropic Hormone Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adrenocorticotropic Hormone Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Adrenocorticotropic Hormone Receptor in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Adrenocorticotropic Hormone Receptor company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Adrenocorticotropic Hormone Receptor revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Adrenocorticotropic Hormone Receptor Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Corticotropin Major Player Table 3. BIM-23B065 Major Player Table 4. AQB-565 Major Player Table 5. Others Major Player Table 6. Global Adrenocorticotropic Hormone Receptor Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Acromegaly Major Player Table 8. Cushing Disease Major Player Table 9. Hormonal Disorder Major Player Table 10. Musculoskeletal Disorder Major Player Table 11. Others Major Player Table 12. Adrenocorticotropic Hormone Receptor Industry Trends Table 13. Adrenocorticotropic Hormone Receptor Industry Drivers Table 14. Adrenocorticotropic Hormone Receptor Industry Opportunities and Challenges Table 15. Adrenocorticotropic Hormone Receptor Industry Restraints Table 16. Global Adrenocorticotropic Hormone Receptor Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Adrenocorticotropic Hormone Receptor Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Adrenocorticotropic Hormone Receptor Market Share by Region (2021-2026) Table 19. Global Adrenocorticotropic Hormone Receptor Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Adrenocorticotropic Hormone Receptor Market Share by Region (2027-2032) Table 21. Global Adrenocorticotropic Hormone Receptor Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Adrenocorticotropic Hormone Receptor Revenue Market Share by Players (2021-2026) Table 23. Global Adrenocorticotropic Hormone Receptor Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Adrenocorticotropic Hormone Receptor Key Players Headquarters & Area Served Table 25. Global Adrenocorticotropic Hormone Receptor Players, Product Type & Application Table 26. Global Adrenocorticotropic Hormone Receptor Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Adrenocorticotropic Hormone Receptor by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Adrenocorticotropic Hormone Receptor Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Adrenocorticotropic Hormone Receptor Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Adrenocorticotropic Hormone Receptor Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Adrenocorticotropic Hormone Receptor Revenue Market Share by Type (2021-2026) Table 33. Global Adrenocorticotropic Hormone Receptor Revenue Market Share by Type (2027-2032) Table 34. Global Adrenocorticotropic Hormone Receptor Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Adrenocorticotropic Hormone Receptor Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Adrenocorticotropic Hormone Receptor Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Adrenocorticotropic Hormone Receptor Revenue Market Share by Application (2021-2026) Table 38. Global Adrenocorticotropic Hormone Receptor Revenue Market Share by Application (2027-2032) Table 39. Pfizer Inc. Company Information Table 40. Pfizer Inc. Business Overview Table 41. Pfizer Inc. Adrenocorticotropic Hormone Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Pfizer Inc. Adrenocorticotropic Hormone Receptor Product Portfolio Table 43. Pfizer Inc. Recent Development Table 44. XOMA Corporation Company Information Table 45. XOMA Corporation Business Overview Table 46. XOMA Corporation Adrenocorticotropic Hormone Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. XOMA Corporation Adrenocorticotropic Hormone Receptor Product Portfolio Table 48. XOMA Corporation Recent Development Table 49. Retrophin Inc. Company Information Table 50. Retrophin Inc. Business Overview Table 51. Retrophin Inc. Adrenocorticotropic Hormone Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Retrophin Inc. Adrenocorticotropic Hormone Receptor Product Portfolio Table 53. Retrophin Inc. Recent Development Table 54. Mallinckrodt Plc Company Information Table 55. Mallinckrodt Plc Business Overview Table 56. Mallinckrodt Plc Adrenocorticotropic Hormone Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Mallinckrodt Plc Adrenocorticotropic Hormone Receptor Product Portfolio Table 58. Mallinckrodt Plc Recent Development Table 59. Ipsen S.A. Company Information Table 60. Ipsen S.A. Business Overview Table 61. Ipsen S.A. Adrenocorticotropic Hormone Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Ipsen S.A. Adrenocorticotropic Hormone Receptor Product Portfolio Table 63. Ipsen S.A. Recent Development Table 64. Alder Biopharmaceuticals Inc. Company Information Table 65. Alder Biopharmaceuticals Inc. Business Overview Table 66. Alder Biopharmaceuticals Inc. Adrenocorticotropic Hormone Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Alder Biopharmaceuticals Inc. Adrenocorticotropic Hormone Receptor Product Portfolio Table 68. Alder Biopharmaceuticals Inc. Recent Development Table 69. North America Adrenocorticotropic Hormone Receptor Revenue by Type (2021-2026) & (US$ Million) Table 70. North America Adrenocorticotropic Hormone Receptor Revenue by Type (2027-2032) & (US$ Million) Table 71. North America Adrenocorticotropic Hormone Receptor Revenue by Application (2021-2026) & (US$ Million) Table 72. North America Adrenocorticotropic Hormone Receptor Revenue by Application (2027-2032) & (US$ Million) Table 73. North America Adrenocorticotropic Hormone Receptor Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. North America Adrenocorticotropic Hormone Receptor Revenue by Country (2021-2026) & (US$ Million) Table 75. North America Adrenocorticotropic Hormone Receptor Revenue by Country (US$ Million) & (2027-2032) Table 76. Europe Adrenocorticotropic Hormone Receptor Revenue by Type (2021-2026) & (US$ Million) Table 77. Europe Adrenocorticotropic Hormone Receptor Revenue by Type (2027-2032) & (US$ Million) Table 78. Europe Adrenocorticotropic Hormone Receptor Revenue by Application (2021-2026) & (US$ Million) Table 79. Europe Adrenocorticotropic Hormone Receptor Revenue by Application (2027-2032) & (US$ Million) Table 80. Europe Adrenocorticotropic Hormone Receptor Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. Europe Adrenocorticotropic Hormone Receptor Revenue by Country (2021-2026) & (US$ Million) Table 82. Europe Adrenocorticotropic Hormone Receptor Revenue by Country (US$ Million) & (2027-2032) Table 83. China Adrenocorticotropic Hormone Receptor Revenue by Type (2021-2026) & (US$ Million) Table 84. China Adrenocorticotropic Hormone Receptor Revenue by Type (2027-2032) & (US$ Million) Table 85. China Adrenocorticotropic Hormone Receptor Revenue by Application (2021-2026) & (US$ Million) Table 86. China Adrenocorticotropic Hormone Receptor Revenue by Application (2027-2032) & (US$ Million) Table 87. Asia Adrenocorticotropic Hormone Receptor Revenue by Type (2021-2026) & (US$ Million) Table 88. Asia Adrenocorticotropic Hormone Receptor Revenue by Type (2027-2032) & (US$ Million) Table 89. Asia Adrenocorticotropic Hormone Receptor Revenue by Application (2021-2026) & (US$ Million) Table 90. Asia Adrenocorticotropic Hormone Receptor Revenue by Application (2027-2032) & (US$ Million) Table 91. Asia Adrenocorticotropic Hormone Receptor Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Asia Adrenocorticotropic Hormone Receptor Revenue by Region (US$ Million) & (2021-2026) Table 93. Asia Adrenocorticotropic Hormone Receptor Revenue by Region (US$ Million) & (2027-2032) Table 94. SAMEA Adrenocorticotropic Hormone Receptor Revenue by Type (2021-2026) & (US$ Million) Table 95. SAMEA Adrenocorticotropic Hormone Receptor Revenue by Type (2027-2032) & (US$ Million) Table 96. SAMEA Adrenocorticotropic Hormone Receptor Revenue by Application (2021-2026) & (US$ Million) Table 97. SAMEA Adrenocorticotropic Hormone Receptor Revenue by Application (2027-2032) & (US$ Million) Table 98. SAMEA Adrenocorticotropic Hormone Receptor Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. SAMEA Adrenocorticotropic Hormone Receptor Revenue by Country (2021-2026) & (US$ Million) Table 100. SAMEA Adrenocorticotropic Hormone Receptor Revenue by Country (US$ Million) & (2027-2032) Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Adrenocorticotropic Hormone Receptor Image Figure 2. Global Adrenocorticotropic Hormone Receptor Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Adrenocorticotropic Hormone Receptor Market Size Share 2021 VS 2025 VS 2032 Figure 4. Corticotropin Image Figure 5. BIM-23B065 Image Figure 6. AQB-565 Image Figure 7. Others Image Figure 8. Global Adrenocorticotropic Hormone Receptor Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Adrenocorticotropic Hormone Receptor Market Size Share 2021 VS 2025 VS 2032 Figure 10. Acromegaly Image Figure 11. Cushing Disease Image Figure 12. Hormonal Disorder Image Figure 13. Musculoskeletal Disorder Image Figure 14. Others Image Figure 15. Global Adrenocorticotropic Hormone Receptor Market Size (US$ Million) & (2021-2032) Figure 16. Global Adrenocorticotropic Hormone Receptor Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Adrenocorticotropic Hormone Receptor Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Adrenocorticotropic Hormone Receptor Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Adrenocorticotropic Hormone Receptor Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Adrenocorticotropic Hormone Receptor Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Adrenocorticotropic Hormone Receptor Revenue Market Share by Type (2021-2032) Figure 23. Global Adrenocorticotropic Hormone Receptor Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Adrenocorticotropic Hormone Receptor Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Adrenocorticotropic Hormone Receptor Revenue Market Share by Application (2021-2032) Figure 26. North America Adrenocorticotropic Hormone Receptor Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Adrenocorticotropic Hormone Receptor Revenue Share by Type (2021-2032) Figure 28. North America Adrenocorticotropic Hormone Receptor Revenue Share by Application (2021-2032) Figure 29. North America Adrenocorticotropic Hormone Receptor Revenue Share by Country (2021-2032) Figure 30. United States Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Adrenocorticotropic Hormone Receptor Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Adrenocorticotropic Hormone Receptor Revenue Share by Type (2021-2032) Figure 35. Europe Adrenocorticotropic Hormone Receptor Revenue Share by Application (2021-2032) Figure 36. Europe Adrenocorticotropic Hormone Receptor Revenue Share by Country (2021-2032) Figure 37. Germany Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Adrenocorticotropic Hormone Receptor Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Adrenocorticotropic Hormone Receptor Revenue Share by Type (2021-2032) Figure 47. China Adrenocorticotropic Hormone Receptor Revenue Share by Application (2021-2032) Figure 48. Asia Adrenocorticotropic Hormone Receptor Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Adrenocorticotropic Hormone Receptor Revenue Share by Type (2021-2032) Figure 50. Asia Adrenocorticotropic Hormone Receptor Revenue Share by Application (2021-2032) Figure 51. Asia Adrenocorticotropic Hormone Receptor Revenue Share by Region (2021-2032) Figure 52. Japan Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Adrenocorticotropic Hormone Receptor Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Adrenocorticotropic Hormone Receptor Revenue Share by Type (2021-2032) Figure 60. SAMEA Adrenocorticotropic Hormone Receptor Revenue Share by Application (2021-2032) Figure 61. SAMEA Adrenocorticotropic Hormone Receptor Revenue Share by Country (2021-2032) Figure 62. Brazil Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Adrenocorticotropic Hormone Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Corticotropin
  • BIM-23B065
  • AQB-565
  • Others
Applications
  • Acromegaly
  • Cushing Disease
  • Hormonal Disorder
  • Musculoskeletal Disorder
  • Others
Companies covered
  • Pfizer Inc.
  • XOMA Corporation
  • Retrophin Inc.
  • Mallinckrodt Plc
  • Ipsen S.A.
  • Alder Biopharmaceuticals Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Adrenocorticotropic Hormone Receptor Market by Type
  3. 1.2.1 Global Adrenocorticotropic Hormone Receptor Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Corticotropin
  5. 1.2.3 BIM-23B065
  6. 1.2.4 AQB-565
  7. 1.2.5 Others
  8. 1.3 Adrenocorticotropic Hormone Receptor Market by Application
  9. 1.3.1 Global Adrenocorticotropic Hormone Receptor Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Acromegaly
  11. 1.3.3 Cushing Disease
  12. 1.3.4 Hormonal Disorder
  13. 1.3.5 Musculoskeletal Disorder
  14. 1.3.6 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Adrenocorticotropic Hormone Receptor Market Dynamics
  1. 2.1 Adrenocorticotropic Hormone Receptor Industry Trends
  2. 2.2 Adrenocorticotropic Hormone Receptor Industry Drivers
  3. 2.3 Adrenocorticotropic Hormone Receptor Industry Opportunities and Challenges
  4. 2.4 Adrenocorticotropic Hormone Receptor Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Adrenocorticotropic Hormone Receptor Market Perspective (2021-2032)
  2. 3.2 Global Adrenocorticotropic Hormone Receptor Growth Trends by Region
  3. 3.2.1 Global Adrenocorticotropic Hormone Receptor Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Adrenocorticotropic Hormone Receptor Market Size by Region (2021-2026)
  5. 3.2.3 Global Adrenocorticotropic Hormone Receptor Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Adrenocorticotropic Hormone Receptor Revenue by Players
  2. 4.1.1 Global Adrenocorticotropic Hormone Receptor Revenue by Players (2021-2026)
  3. 4.1.2 Global Adrenocorticotropic Hormone Receptor Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Adrenocorticotropic Hormone Receptor Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Adrenocorticotropic Hormone Receptor Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Adrenocorticotropic Hormone Receptor Key Players Headquarters & Area Served
  7. 4.4 Global Adrenocorticotropic Hormone Receptor Players, Product Type & Application
  8. 4.5 Global Adrenocorticotropic Hormone Receptor Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Adrenocorticotropic Hormone Receptor Market CR5 and HHI
  11. 4.6.3 2025 Adrenocorticotropic Hormone Receptor Tier 1, Tier 2, and Tier 3
5 Adrenocorticotropic Hormone Receptor Market Size by Type
  1. 5.1 Global Adrenocorticotropic Hormone Receptor Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Adrenocorticotropic Hormone Receptor Revenue by Type (2021-2032)
  3. 5.3 Global Adrenocorticotropic Hormone Receptor Revenue Market Share by Type (2021-2032)
6 Adrenocorticotropic Hormone Receptor Market Size by Application
  1. 6.1 Global Adrenocorticotropic Hormone Receptor Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Adrenocorticotropic Hormone Receptor Revenue by Application (2021-2032)
  3. 6.3 Global Adrenocorticotropic Hormone Receptor Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Pfizer Inc.
  2. 7.1.1 Pfizer Inc. Company Information
  3. 7.1.2 Pfizer Inc. Business Overview
  4. 7.1.3 Pfizer Inc. Adrenocorticotropic Hormone Receptor Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Pfizer Inc. Adrenocorticotropic Hormone Receptor Product Portfolio
  6. 7.1.5 Pfizer Inc. Recent Developments
  7. 7.2 XOMA Corporation
  8. 7.2.1 XOMA Corporation Company Information
  9. 7.2.2 XOMA Corporation Business Overview
  10. 7.2.3 XOMA Corporation Adrenocorticotropic Hormone Receptor Revenue and Gross Margin (2021-2026)
  11. 7.2.4 XOMA Corporation Adrenocorticotropic Hormone Receptor Product Portfolio
  12. 7.2.5 XOMA Corporation Recent Developments
  13. 7.3 Retrophin Inc.
  14. 7.3.1 Retrophin Inc. Company Information
  15. 7.3.2 Retrophin Inc. Business Overview
  16. 7.3.3 Retrophin Inc. Adrenocorticotropic Hormone Receptor Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Retrophin Inc. Adrenocorticotropic Hormone Receptor Product Portfolio
  18. 7.3.5 Retrophin Inc. Recent Developments
  19. 7.4 Mallinckrodt Plc
  20. 7.4.1 Mallinckrodt Plc Company Information
  21. 7.4.2 Mallinckrodt Plc Business Overview
  22. 7.4.3 Mallinckrodt Plc Adrenocorticotropic Hormone Receptor Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Mallinckrodt Plc Adrenocorticotropic Hormone Receptor Product Portfolio
  24. 7.4.5 Mallinckrodt Plc Recent Developments
  25. 7.5 Ipsen S.A.
  26. 7.5.1 Ipsen S.A. Company Information
  27. 7.5.2 Ipsen S.A. Business Overview
  28. 7.5.3 Ipsen S.A. Adrenocorticotropic Hormone Receptor Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Ipsen S.A. Adrenocorticotropic Hormone Receptor Product Portfolio
  30. 7.5.5 Ipsen S.A. Recent Developments
  31. 7.6 Alder Biopharmaceuticals Inc.
  32. 7.6.1 Alder Biopharmaceuticals Inc. Company Information
  33. 7.6.2 Alder Biopharmaceuticals Inc. Business Overview
  34. 7.6.3 Alder Biopharmaceuticals Inc. Adrenocorticotropic Hormone Receptor Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Alder Biopharmaceuticals Inc. Adrenocorticotropic Hormone Receptor Product Portfolio
  36. 7.6.5 Alder Biopharmaceuticals Inc. Recent Developments
8 North America
  1. 8.1 North America Adrenocorticotropic Hormone Receptor Revenue (2021-2032)
  2. 8.2 North America Adrenocorticotropic Hormone Receptor Revenue by Type (2021-2032)
  3. 8.2.1 North America Adrenocorticotropic Hormone Receptor Revenue by Type (2021-2026)
  4. 8.2.2 North America Adrenocorticotropic Hormone Receptor Revenue by Type (2027-2032)
  5. 8.3 North America Adrenocorticotropic Hormone Receptor Revenue Share by Type (2021-2032)
  6. 8.4 North America Adrenocorticotropic Hormone Receptor Revenue by Application (2021-2032)
  7. 8.4.1 North America Adrenocorticotropic Hormone Receptor Revenue by Application (2021-2026)
  8. 8.4.2 North America Adrenocorticotropic Hormone Receptor Revenue by Application (2027-2032)
  9. 8.5 North America Adrenocorticotropic Hormone Receptor Revenue Share by Application (2021-2032)
  10. 8.6 North America Adrenocorticotropic Hormone Receptor Revenue by Country
  11. 8.6.1 North America Adrenocorticotropic Hormone Receptor Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Adrenocorticotropic Hormone Receptor Revenue by Country (2021-2026)
  13. 8.6.3 North America Adrenocorticotropic Hormone Receptor Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Adrenocorticotropic Hormone Receptor Revenue (2021-2032)
  2. 9.2 Europe Adrenocorticotropic Hormone Receptor Revenue by Type (2021-2032)
  3. 9.2.1 Europe Adrenocorticotropic Hormone Receptor Revenue by Type (2021-2026)
  4. 9.2.2 Europe Adrenocorticotropic Hormone Receptor Revenue by Type (2027-2032)
  5. 9.3 Europe Adrenocorticotropic Hormone Receptor Revenue Share by Type (2021-2032)
  6. 9.4 Europe Adrenocorticotropic Hormone Receptor Revenue by Application (2021-2032)
  7. 9.4.1 Europe Adrenocorticotropic Hormone Receptor Revenue by Application (2021-2026)
  8. 9.4.2 Europe Adrenocorticotropic Hormone Receptor Revenue by Application (2027-2032)
  9. 9.5 Europe Adrenocorticotropic Hormone Receptor Revenue Share by Application (2021-2032)
  10. 9.6 Europe Adrenocorticotropic Hormone Receptor Revenue by Country
  11. 9.6.1 Europe Adrenocorticotropic Hormone Receptor Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Adrenocorticotropic Hormone Receptor Revenue by Country (2021-2026)
  13. 9.6.3 Europe Adrenocorticotropic Hormone Receptor Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Adrenocorticotropic Hormone Receptor Revenue (2021-2032)
  2. 10.2 China Adrenocorticotropic Hormone Receptor Revenue by Type (2021-2032)
  3. 10.2.1 China Adrenocorticotropic Hormone Receptor Revenue by Type (2021-2026)
  4. 10.2.2 China Adrenocorticotropic Hormone Receptor Revenue by Type (2027-2032)
  5. 10.3 China Adrenocorticotropic Hormone Receptor Revenue Share by Type (2021-2032)
  6. 10.4 China Adrenocorticotropic Hormone Receptor Revenue by Application (2021-2032)
  7. 10.4.1 China Adrenocorticotropic Hormone Receptor Revenue by Application (2021-2026)
  8. 10.4.2 China Adrenocorticotropic Hormone Receptor Revenue by Application (2027-2032)
  9. 10.5 China Adrenocorticotropic Hormone Receptor Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Adrenocorticotropic Hormone Receptor Revenue (2021-2032)
  2. 11.2 Asia Adrenocorticotropic Hormone Receptor Revenue by Type (2021-2032)
  3. 11.2.1 Asia Adrenocorticotropic Hormone Receptor Revenue by Type (2021-2026)
  4. 11.2.2 Asia Adrenocorticotropic Hormone Receptor Revenue by Type (2027-2032)
  5. 11.3 Asia Adrenocorticotropic Hormone Receptor Revenue Share by Type (2021-2032)
  6. 11.4 Asia Adrenocorticotropic Hormone Receptor Revenue by Application (2021-2032)
  7. 11.4.1 Asia Adrenocorticotropic Hormone Receptor Revenue by Application (2021-2026)
  8. 11.4.2 Asia Adrenocorticotropic Hormone Receptor Revenue by Application (2027-2032)
  9. 11.5 Asia Adrenocorticotropic Hormone Receptor Revenue Share by Application (2021-2032)
  10. 11.6 Asia Adrenocorticotropic Hormone Receptor Revenue by Country
  11. 11.6.1 Asia Adrenocorticotropic Hormone Receptor Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Adrenocorticotropic Hormone Receptor Revenue by Country (2021-2026)
  13. 11.6.3 Asia Adrenocorticotropic Hormone Receptor Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Adrenocorticotropic Hormone Receptor Revenue (2021-2032)
  2. 12.2 SAMEA Adrenocorticotropic Hormone Receptor Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Adrenocorticotropic Hormone Receptor Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Adrenocorticotropic Hormone Receptor Revenue by Type (2027-2032)
  5. 12.3 SAMEA Adrenocorticotropic Hormone Receptor Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Adrenocorticotropic Hormone Receptor Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Adrenocorticotropic Hormone Receptor Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Adrenocorticotropic Hormone Receptor Revenue by Application (2027-2032)
  9. 12.5 SAMEA Adrenocorticotropic Hormone Receptor Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Adrenocorticotropic Hormone Receptor Revenue by Country
  11. 12.6.1 SAMEA Adrenocorticotropic Hormone Receptor Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Adrenocorticotropic Hormone Receptor Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Adrenocorticotropic Hormone Receptor Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst